diabetic macular oedema

News

Genetic testing hopes to speed up drug development in rare eye diseases

Oxurion reports stronger data for diabetic eye disease drug

Belgian biotech Oxurion has revealed new data from a phase 2 trial of its plasma kallikrein inhibitor THR-149, in development for people with

News

Novartis says trials back Beovu safety in diabetic eye disea...

There is plenty of evidence that Novartis' ophthalmology drug Beovu can match its rivals when it comes to efficacy, with less frequent dosing, but the big question facing the company is whe

News

FDA starts review of Roche's eye disease drug, setting up 20...

The FDA has started a priority review of Roche's bispecific antibody faricimab for two major causes of blindness, preparing for a market showdown with Bayer and Regeneron's market-leading E

News